Vancomycin-resistant Staphylococcus aureus--New York, 2004.
Staphylococcus aureus is a common cause of hospital- and community-acquired infections. The development of vancomycin-resistant enterococci in 1988 led the way to the emergence of vancomycin-resistant S. aureus (VRSA) (minimum inhibitory concentration [MIC] > or =32 microg/mL [3]), first recognized in 2002. This report describes the third documented clinical isolate of VRSA from a patient in the United States and provides evidence of failure to detect this VRSA by commonly used automated antimicrobial susceptibility testing.
D003428:Cross Infection / Q000517:prevention & control; D006801:Humans; D017053:Infection Control; D008826:Microbial Sensitivity Tests; D009518:New York / Q000453:epidemiology; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D020713:Vancomycin Resistance